Propaten Randomized Investigation on Cost-benefit and Efficacy

NATerminatedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

November 9, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

June 30, 2018

Conditions
End-stage Renal Disease
Interventions
DEVICE

PROPATEN

Heparin-bonded graft implantation for hemodialysis vascular access

DEVICE

Standard Graft

non-heparin bonded conventional hemodialysis vascular access graft

Trial Locations (5)

44106

University Hospitals Cleveland Medical Center, Cleveland

70121

John Ochsner Heart & Vascular Institute Ochsner Medical Center, New Orleans

72205

University of Arkansas for Medical Sciences (UAMS) & Central Arkansas Veterans Healthcare System (CAVHS), Little Rock

77030

Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center, Houston

77089

Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hospital Southeast, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University Hospitals Cleveland Medical Center

OTHER

collaborator

University of Arkansas

OTHER

collaborator

Ochsner Health System

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER